Biogen tops profit estimates as cost cuts take hold, Alzheimer’s drug Leqembi launch picks up
Alzheimer’s drug Leqembi brought in in approximately $19 million in sales for the quarter, up from the $10 million the drug generated last year.
The Australian bank said its first-half net profit fell by 16%, but it would return more capital to shareholders through...
Month’s pullback still leaves performance in the green so far in 2024. Also: A flashback to the 40th anniversary of...
As hopes of interest-rate cuts fade, some commercial real-estate borrowers want to cut loose.
After Russian troops stormed into the country two years ago, Ukraine’s lenders said Kyiv could wait to pay them back....
After years in the doldrums, European banks have cleaned up their balance sheets. The result: Stock prices have surged.
The political conflict over socially conscious finance has Wall Street heavyweights pulling back in Texas, the nation’s top issuer of...
Average Rating